- Combination creates the premier provider of high-tech IT solutions to Government Technology Services market
- With approximately $9.9 billion in revenue and strong double-digit EBITDA margins, the combined GDIT and CSRA is well-positioned to serve its customers’ current and evolving mission requirements
- Expected to generate run-rate pre-tax cost synergies of approximately 2% of combined sales by 2020
- Accretive to earnings and free cash flow per share in 2019
February 19, 2018 08:00 AM Eastern Standard Time
CORALVILLE, Iowa--(BUSINESS WIRE)--Today, Voxello, patient-provider engagement company specializing in solutions for critically ill patients, announced its fourth major distribution partnership with ASCC, Inc., a major U.S. distributor. ASCC partners with hospitals, long term care facilities and clinics in the Western Pennsylvania and Eastern Ohio regions and is now strategically positioned to distribute Voxello’s cutting-edge noddle® technology in this important market.
Austin, TX – Applied Food Sciences, Inc. (AFS) takes the next step in demonstrating complete transparency by getting four of its core ingredients Non-GMO Project Verified. The company’s PurCaf® organic caffeine headlines a list of innovative and sustainably sourced offerings by AFS.
PurCaf® Organic Caffeine – a 95% caffeine extract from organic green coffee beans
PurTea™ Organic Caffeine – a 90% caffeine extract from organic green tea leaves
JAVA.g™ – a polyphenolic blend of caffeine and antioxidants from green coffee beans
CompleWare and VIDA announce a joint marketing agreement promoting complementary respiratory services. Their partnership will deploy a best-in-class pulmonary platform and excellence in clinical trial management, with precision, ISO-certified core lab imaging.
September 8, 2017 (Coralville, IA) – Viewpoint Molecular Targeting, LLC, a University of Iowa start-up pharmaceutical company that has developed a novel therapy and companion diagnostic for metastatic melanoma, announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) Contract Award valued at $2 million from the National Cancer Institute (NCI) to support pre-clinical studies of its lead product, VMT-01.
September 6, 2017 (IOWA CITY, IA) – Viewpoint Molecular Targeting LLC, a University of Iowa spin-out company developing therapies and diagnostics for metastatic melanoma, recently placed first at the Iowa SBIR Showcase (Virtual SBIR Road Tour) pitch competition.
For the third year, the University of Iowa Office of the Vice President for Research and Economic Development (OVPR&ED) helped sponsor the Innovative Software Engineering (ISE) Coding Garage this summer, bringing together 15 high school students from the Iowa City area to create their own mobile apps. Because of the partnership between the Coralville-based ISE and OVPR&ED’s prototyping and 3D rendering resource, protostudios, the workshop was free to students, who met at the UI’s BioVentures Center in Coralville weekly for nine weeks.